No Carolina / NY / Florida
Ph: 561.316.3330

HomeFUNDING

Category: FUNDING

Phenomix Sciences Raises $7.8M in...

Funding will accelerate the commercialization and adoption of the MyPhenome™ test in the obesity specialist market and the wider industry. The MyPhenome test equips physicians with essential tools to develop effective treatment plans including lifestyle and diet intervention as well as medication and/or procedure recommendations reports Phenomix Sciences.

R3 Vascular Announces $87 Million...

R3 Vascular will use the proceeds to support the ELITE FDA IDE pivotal trial of its best-in-class bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD. 

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

Funding will accelerate the commercialization and adoption of the MyPhenome™ test in the obesity specialist market and the wider industry. The MyPhenome test equips physicians with essential tools to develop effective treatment plans including lifestyle and diet intervention as well as medication and/or procedure recommendations reports Phenomix Sciences.

Variantyx Secures $41.5M in Funding

“The funding is a great testament of confidence and trust in the company,” said Haim Neerman, CEO of Variantyx. “It allows us to expand our diagnostic solutions to a wider array of customers so that medical care can become more personalized. The growth of Variantyx has been exponential, and we look forward to sharing the new disruptive products we have in the pipeline.”

Orthox Closes $12.5m Series A Financing

Nick Skaer, co-founder, and CEO of Orthox said: "This $12.5m Series A financing round from a range of high-quality medtech investors reflects the strong progress we are making with our award-winning FibroFix product platform.

CroíValve Raises an €8M Series A Round

The funding will support a European Feasibility Study of the CroíValve Transcatheter Tricuspid DUO Coaptation Valve System.

Damae Medical Raises €5M in Series A Financing

The financial resources offered by this second round of financing of €5 million will enable the company to accelerate the commercial deployment of deepLive™ in Europe and to push the development of our product even further. 

Enable Injections Announces $215 Million in Series C Financing

The funding from Magnetar will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling development and commercialization efforts.

NaoX Technologies Raises €4.3 Million

NaoX was co-founded in 2018 by Hugo Dinh, a graduate from Ecole Polytechnique, and Michel Le Van Quyen, a research director at Inserm, respectively CEO and Chief Scientific Officer.

SetBone Medical Announces $1.6 Million Financing

The funds raised will support the next stage of development and initiation of a First in Human pilot study.

PolyPhotonix Secures Multimillion Pound US Investment and Strategic Alliance for Sight Saving Mask

Prevail Partners, LLC, an affiliate of InfoWorks, has agreed to invest significantly in PolyPhotonix upon the commencement of the FDA clinical trial as lead investor in a $10M Series A investment round. Successful completion of the FDA clinical trial will open the US market to the treatment.

ENPICOM Secures Series B Funding

BOP Capital leads investment round supported by ENPICOM’s existing investors

By using this website you agree to accept Medical Device News Magazine Privacy Policy